Watson Pharmaceuticals (002907.SZ) received 6 drug re-registration approval notices

According to the Zhitong Finance App, Watson Pharmaceutical (002907.SZ) issued an announcement. The company recently received 6 “Drug Re-Registration Approval Notice” approved and issued by the Chongqing Drug Administration. The products involved include: “Analgin tablets (0.25g),” “Analgin tablets (0.5g),” “Duliang softgels,” “vitamin C tablets,” “terazosin hydrochloride capsules,” and “injectable quinine.”

This time, the company obtained the “Drug Re-Registration Approval Notice” to ensure the normal production and sale of the above drugs. The company will carry out related work in strict accordance with the requirements, control product quality, and continue to provide high-quality products to the market.